Amoso-cv 625

Generic Name:
Amoso-cv 625
Therapeutic Category:
Antibacterial / β-lactamase Inhibitor Combination
Mechanism of Action:
Dual-action antibacterial attack. Amoxicillin prevents bacterial cell wall synthesis leading to cell death. Potassium clavulanate inactivates β-lactamase enzymes produced by resistant bacteria, protecting amoxicillin from degradation and extending its spectrum.

Indications

Dosage & Administration

Contraindications & Precautions

Potential Side Effects

Indications (Therapeutic Uses)

This combination tablet is indicated for the treatment of severe, acute bacterial infections caused by susceptible strains when β-lactamase-mediated resistance is suspected:

  • Lower Respiratory Tract Infections: Acute exacerbations of chronic bronchitis and community-acquired pneumonia.
  • Upper Respiratory Tract Infections: Severe acute bacterial sinusitis and acute otitis media (middle ear infection).
  • Urinary Tract Infections (UTIs): Uncomplicated cystitis and complicated pyelonephritis (kidney infection).
  • Skin and Soft Tissue Infections: Severe cellulitis, animal bites, and dental abscesses with spreading cellulitis.

Dosage & Administration

Website Note: Dosage and duration of therapy must be determined by a registered medical practitioner based on the severity, type, and site of infection.

  • Standard Dose: For adults and pediatric patients weighing 40 kg or more, the standard dose is one tablet (500 mg/125 mg) taken three times daily, or one stronger variant twice daily depending on infection severity.
  • Administration: Tablets must be swallowed whole with water—do not crush or chew.
  • Timing: Should be administered at the start of a meal to optimize absorption and significantly minimize potential gastrointestinal intolerance.
  • Course Completion: The full prescribed course must be finished even if symptoms improve early, to prevent the development of bacterial resistance.

Contraindications & Precautions

  • Absolute Contraindications: Do not use in patients with a history of severe hypersensitivity (e.g., anaphylaxis, Stevens-Johnson syndrome) to amoxicillin, penicillin, or any other β-lactam agent (such as cephalosporins). Absolutely contraindicated in patients with a history of cholestatic jaundice or hepatic impairment associated with this combination.
  • Hepatic Toxicity: Hepatic dysfunction (including jaundice and hepatitis) has been reported. It is usually reversible, but severe cases can occur, particularly in elderly or male patients on prolonged treatment.
  • Clostridium difficile-Associated Diarrhea (CDAD): Nearly all antibacterial agents can disrupt normal colon flora, leading to overgrowth of C. difficile, ranging in severity from mild diarrhea to fatal colitis.
  • Mononucleosis Warning: Amoxicillin should not be given to patients suspected of having infectious mononucleosis, as a high percentage of these patients develop an erythematous skin rash when treated with the drug.

Potential Side Effects

  • Common / Mild: Diarrhea, nausea, vomiting, indigestion, abdominal discomfort, and oral or vaginal candidiasis (thrush due to fungal overgrowth).
  • Less Common / Severe: Severe anaphylactic allergic reactions, cholestatic jaundice, elevated liver enzymes, acute interstitial nephritis (kidney inflammation), and severe cutaneous adverse reactions like toxic epidermal necrolysis.
Soins Heaalthcare Logo

Designed & Developed By The Brand Projects

Linkedin-in